116 related articles for article (PubMed ID: 38591191)
1. Chondroitin polymerizing factor (CHPF) promotes the progression of colorectal cancer through ASB2-mediated ubiquitylation of SMAD9.
Zhao J; Tang X; Zhu H
Histol Histopathol; 2024 Mar; ():18738. PubMed ID: 38591191
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB.
Huang Y; Zhang Z; Tong H; Qin W; Li Q; Ma L; Ren Z; Chen W; Zhang Y; Zhong Y; Yao L; Zhou P
J Cell Mol Med; 2024 May; 28(10):e18268. PubMed ID: 38775031
[TBL] [Abstract][Full Text] [Related]
3. CHPF promotes gastric cancer tumorigenesis through the activation of E2F1.
Lin X; Han T; Xia Q; Cui J; Zhuo M; Liang Y; Su W; Wang L; Wang L; Liu Z; Xiao X
Cell Death Dis; 2021 Sep; 12(10):876. PubMed ID: 34564711
[TBL] [Abstract][Full Text] [Related]
4. Activation of CHPF by transcription factor NFIC promotes NLRP3 activation during the progression of colorectal cancer.
Wu J; Wang M; Zhang Y; Liu G; Xing Y
Funct Integr Genomics; 2024 Jan; 24(1):20. PubMed ID: 38267731
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin polymerizing factor promotes breast carcinoma cell proliferation, invasion and migration and affects expression of epithelial-mesenchymal transition-related markers.
Li Y; Gong H; Feng L; Mao D; Xiao Y; Wang Y; Huang L
FEBS Open Bio; 2021 Feb; 11(2):423-434. PubMed ID: 33301643
[TBL] [Abstract][Full Text] [Related]
6. MiR-214-3p overexpression-triggered chondroitin polymerizing factor (CHPF) inhibition modulates the ferroptosis and metabolism in colon cancer.
Yun ZY; Wu D; Wang X; Huang P; Li N
Kaohsiung J Med Sci; 2024 Mar; 40(3):244-254. PubMed ID: 38190270
[TBL] [Abstract][Full Text] [Related]
7. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-β1/SMAD3 and JNK axis activation.
Pan QF; Ouyang WW; Zhang MQ; He S; Yang SY; Zhang J
J Cell Commun Signal; 2023 Mar; 17(1):89-102. PubMed ID: 36042157
[TBL] [Abstract][Full Text] [Related]
8. Identification of chondroitin polymerizing factor (CHPF) as tumor promotor in cholangiocarcinoma through regulating cell proliferation, cell apoptosis and cell migration.
Duan X; Yang J; Jiang B; Duan W; Wei R; Zhang H; Mao X
Cell Cycle; 2021; 20(5-6):591-602. PubMed ID: 33651657
[TBL] [Abstract][Full Text] [Related]
9. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin Polymerizing Factor (CHPF) promotes cell proliferation and tumor growth in human osteosarcoma by inhibiting SKP2's ubiquitination while activating the AKT pathway.
Shen Y; Li J; Peng D; Liao L; Chen X; Zhong W; Liu Z; Yu C; Sun Y
Genes Dis; 2023 Sep; 10(5):2125-2136. PubMed ID: 37492722
[TBL] [Abstract][Full Text] [Related]
11. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
Hou XM; Zhang T; Da Z; Wu XA
Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
[TBL] [Abstract][Full Text] [Related]
12. Chondroitin polymerizing factor (CHPF) contributes to malignant proliferation and migration of hepatocellular carcinoma cells.
Xu Q; Lin W; Tao C; Huang X; Li J
Biochem Cell Biol; 2020 Jun; 98(3):362-369. PubMed ID: 32383983
[TBL] [Abstract][Full Text] [Related]
13. ASB2 is a novel E3 ligase of SMAD9 required for cardiogenesis.
Min KD; Asakura M; Shirai M; Yamazaki S; Ito S; Fu HY; Asanuma H; Asano Y; Minamino T; Takashima S; Kitakaze M
Sci Rep; 2021 Nov; 11(1):23056. PubMed ID: 34845242
[TBL] [Abstract][Full Text] [Related]
14. Exploring the correlation of glycolysis-related chondroitin polymerizing factor (
Zhong Q; Jiang K; Zhang F; Tian Y; Gu J; Li T; Chen X; Yang J; Sun F
Am J Cancer Res; 2023; 13(6):2213-2233. PubMed ID: 37424829
[TBL] [Abstract][Full Text] [Related]
15. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma.
Luo H; Huang K; Cheng M; Long X; Zhu X; Wu M
Aging (Albany NY); 2023 Oct; 15(20):11052-11066. PubMed ID: 37851364
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
Front Oncol; 2022; 12():856712. PubMed ID: 35372047
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro.
Fan YH; Xiao B; Lv SG; Ye MH; Zhu XG; Wu MJ
Oncol Rep; 2017 Aug; 38(2):1149-1155. PubMed ID: 28627702
[TBL] [Abstract][Full Text] [Related]
18. TGF-β Stimulates Expression of Chondroitin Polymerizing Factor in Nucleus Pulposus Cells Through the Smad3, RhoA/ROCK1, and MAPK Signaling Pathways.
Hu B; Xu C; Cao P; Tian Y; Zhang Y; Shi C; Xu J; Yuan W; Chen H
J Cell Biochem; 2018 Jan; 119(1):566-579. PubMed ID: 28608941
[TBL] [Abstract][Full Text] [Related]
19. CHPF Regulates the Aggressive Phenotypes of Hepatocellular Carcinoma Cells via the Modulation of the Decorin and TGF-β Pathways.
Liu CH; Wu BR; Ho YJ; Chu YH; Hsu WC; Tseng TJ; Li JP; Liao WC
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809195
[TBL] [Abstract][Full Text] [Related]
20. Targeting chondroitin sulfate suppresses macropinocytosis of breast cancer cells by modulating syndecan-1 expression.
Yen HR; Liao WC; Chen CH; Su YA; Huang YW; Hsiao C; Chou YL; Chu YH; Shih PK; Liu CH
Mol Oncol; 2024 May; ():. PubMed ID: 38770553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]